Skip to content
Biodatica
Start free

Investigator

Keith Wycoff

PLANET BIOTECHNOLOGY, INC. · funded by NIAID

Companies
3

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$1.2M

Summed across those awards.

First award
Apr 4, 2024

Latest Aug 1, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    Bispecific antibody for topical administration to prevent gonorrhea

    $300k

    Aug 1, 2024NIAIDPLANET BIOTECHNOLOGY, INC.NIH RePORTER · 11146691 (opens the source filing in a new tab)

  2. R41

    Developing a Potent Broad-Spectrum Prophylactic for Tickborne Disease

    $300k

    Jul 17, 2024NIAIDPLANET BIOTECHNOLOGY, INC.NIH RePORTER · 11140476 (opens the source filing in a new tab)

  3. R43

    Factor H-Fc Fusion as a Pre-Exposure Prophylactic for Rickettsia Infections

    $295k

    Jul 10, 2024NIAIDPLANET BIOTECHNOLOGY, INC.NIH RePORTER · 11136342 (opens the source filing in a new tab)

  4. R41

    A broad spectrum anti-gonorrhea immunotherapeutic

    $297k

    Apr 4, 2024NIAIDPLANET BIOTECHNOLOGY, INC.NIH RePORTER · 11066542 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources